Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeting protein kinases involved in cancer and inflammatory diseases. Its structure allows selective modification to enhance binding affinity and specificity in drug candidates. Also explored in the development of antiviral agents due to its nucleoside analog-like framework. Commonly employed in structure-activity relationship (SAR) studies to optimize potency and pharmacokinetic properties in early-stage drug discovery.